Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 164.695
-0.372 %
$ 8.42 B
Market Cap
823.47
P/E
CRL - STOCK-BASED COMPENSATION
Stock-based Compensation CRL - Charles River Laboratories International, Inc.
69.9 M
LAST VALUE
-2.56%
2 YEAR CAGR
4.06%
5 YEAR CAGR
8.46%
10 YEAR CAGR